Jumpcan Pharmaceutical

Jumpcan Pharmaceutical is one of the...

• CSI 500.

Jumpcan Pharmaceutical is a company listed under the stock ticker 600566 (CN).

View the org chart displaying its 11 main executives

Most searched biographies at Jumpcan Pharmaceutical

• Fei Cao, Vice Chairman of the Board and General Manager
• Hong Yao, Director
• Qian Zhao, Director

Create your alert
to follow the executive moves at Jumpcan Pharmaceutical.

Jumpcan Pharmaceutical has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Jumpcan Pharmaceutical

Social media about Jumpcan Pharmaceutical

• Jumpcan Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Jumpcan Pharmaceutical on LinkedIn, Twitter & YouTube

Contact by email its executives including Wei Cao

Call Jumpcan Pharmaceutical at +86 523 ...

View the org chart

Register to receive your alert

Report an error